Co-Diagnostics CODX
NASDAQ CODX
$0.26 -0.01 (-3.70%)
At close: Nov 13, 2026 · 4:00 PM EST

Co-Diagnostics (CODX) Non-Current Deferred Tax Liability (2020 - 2024)

Updated

Co-Diagnostics (CODX) posted Non-Current Deferred Tax Liability of -$394,244 for Q4 2024, compared with -$2.07 million a year earlier.

Analysis

Co-Diagnostics (CODX) Non-Current Deferred Tax Liability (2020 - 2024) Analysis & Trends

Since Q4 2020, Co-Diagnostics has reported Non-Current Deferred Tax Liability for 9 quarters.

  • In prior years, Co-Diagnostics' Non-Current Deferred Tax Liability was -$2.07 million in FY2023, $2.42 million in FY2022 (-66.5%), $7.23 million in FY2021 and $547,224 in FY2020.
  • The Q4 2024 figure stands as the highest quarterly Non-Current Deferred Tax Liability since Q1 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 259.44 Bn 236.08 Bn 5.13 Bn
2 Abbott Laboratories 187.98 Bn 162.45 Bn 7.39 Bn
3 Danaher 163.91 Bn 143.58 Bn 3.84 Bn
4 Intuitive Surgical 153.75 Bn 134.17 Bn 2.08 Bn
5 Medtronic 131.67 Bn 97.80 Bn 6.34 Bn
6 Stryker 117.84 Bn 104.03 Bn 4.25 Bn
7 Boston Scientific 64.27 Bn 59.95 Bn 3.43 Bn
8 Edwards Lifesciences 61.69 Bn 45.00 Bn 1.35 Bn
9 Medline 51.94 Bn 49.07 Bn 1.93 Bn
10 Co-Diagnostics 1.90 Mn -22.58 Mn -20,463.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 -394,244.00
Dec 31, 2023 -2.07 Mn
Mar 31, 2023 203,335.00
Dec 31, 2022 2.42 Mn
Sep 30, 2022 3.80 Mn
Jun 30, 2022 5.31 Mn
Mar 31, 2022 5.87 Mn
Dec 31, 2021 7.23 Mn
Dec 31, 2020 547,224.00
API Access

Co-Diagnostics Non-Current Deferred Tax Liability API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deferred-tax-liability&ticker=CODX&period=max&api_key=YOUR_API_KEY